O'Keefe Stevens Advisory’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.7M | Sell |
51,752
-29
| -0.1% | -$9.93K | 3.84% | 11 |
|
|
2026
Q1 | $18.2M | Buy |
51,781
+1,172
| +2% | +$418K | 4.5% | 7 |
|
|
2025
Q4 | $16.6M | Buy |
50,609
+134
| +0.3% | +$42.5K | 4.3% | 7 |
|
|
2025
Q3 | $14.2M | Buy |
50,475
+495
| +1% | +$144K | 3.86% | 11 |
|
|
2025
Q2 | $14M | Buy |
49,980
+981
| +2% | +$278K | 3.92% | 7 |
|
|
2025
Q1 | $15.3M | Buy |
48,999
+991
| +2% | +$293K | 5.01% | 4 |
|
|
2024
Q4 | $12.5M | Buy |
48,008
+457
| +1% | +$136K | 3.87% | 8 |
|
|
2024
Q3 | $15.3M | Sell |
47,551
-91
| -0.2% | -$29.8K | 4.64% | 4 |
|
|
2024
Q2 | $14.9M | Sell |
47,642
-745
| -2% | -$219K | 4.97% | 4 |
|
|
2024
Q1 | $13.8M | Buy |
48,387
+42
| +0.1% | +$12.3K | 4.52% | 4 |
|
|
2023
Q4 | $13.9M | Sell |
48,345
-129
| -0.3% | -$35.1K | 5.61% | 4 |
|
|
2023
Q3 | $13M | Buy |
48,474
+571
| +1% | +$142K | 5.93% | 4 |
|
|
2023
Q2 | $10.6M | Buy |
47,903
+1,095
| +2% | +$254K | 4.57% | 3 |
|
|
2023
Q1 | $11.3M | Sell |
46,808
-246
| -0.5% | -$60.4K | 5.59% | 3 |
|
|
2022
Q4 | $12.4M | Buy |
47,054
+6
| +0% | +$1.61K | 7.34% | 3 |
|
|
2022
Q3 | $10.6M | Buy |
47,048
+376
| +0.8% | +$91.1K | 7.17% | 3 |
|
|
2022
Q2 | $11.4M | Buy |
46,672
+29
| +0.1% | +$7.11K | 6.96% | 3 |
|
|
2022
Q1 | $11.3M | Buy |
46,643
+1,141
| +3% | +$262K | 5.5% | 3 |
|
|
2021
Q4 | $10.2M | Buy |
45,502
+797
| +2% | +$168K | 4.81% | 4 |
|
|
2021
Q3 | $9.51M | Sell |
44,705
-401
| -0.9% | -$92.3K | 5.2% | 4 |
|
|
2021
Q2 | $11M | Buy |
45,106
+575
| +1% | +$141K | 5.86% | 4 |
|
|
2021
Q1 | $11M | Buy |
44,531
+100
| +0.2% | +$23.9K | 6.94% | 4 |
|
|
2020
Q4 | $10.2M | Sell |
44,431
-1,053
| -2% | -$243K | 7% | 3 |
|
|
2020
Q3 | $11.6M | Sell |
45,484
-430
| -0.9% | -$107K | 9% | 2 |
|
|
2020
Q2 | $10.8M | Buy |
+45,914
| New | +$10.5M | 9.38% | 2 |
|
|
2019
Q4 | $11.2M | Sell |
46,441
-675
| -1% | -$149K | 8.44% | 2 |
|
|
2019
Q3 | $9.12M | Buy |
47,116
+212
| +0.5% | +$40.7K | 7.02% | 2 |
|
|
2019
Q2 | $8.64M | Buy |
46,904
+658
| +1% | +$118K | 6.45% | 3 |
|
|
2019
Q1 | $8.79M | Buy |
46,246
+295
| +0.6% | +$56.3K | 6.83% | 2 |
|
|
2018
Q4 | $8.95M | Sell |
45,951
-533
| -1% | -$104K | 8.05% | 1 |
|
|
2018
Q3 | $9.64M | Sell |
46,484
-17
| -0% | -$3.35K | 6.82% | 2 |
|
|
2018
Q2 | $8.58M | Buy |
46,501
+23,380
| +101% | +$4.14M | 6.84% | 2 |
|
|
2018
Q1 | $3.94M | Buy |
23,121
+1,603
| +7% | +$294K | 3.48% | 10 |
|
|
2017
Q4 | $3.74M | Buy |
21,518
+985
| +5% | +$174K | 3.39% | 11 |
|
|
2017
Q3 | $3.83M | Buy |
+20,533
| New | +$3.64M | 3.55% | 6 |
|
Other funds holding AMGN
FFM
SP
O'Keefe Stevens Advisory's AMGN Position: Q2 2026 in Review
O'Keefe Stevens Advisory reduced its Amgen (AMGN) stake by 0.06% in Q2 2026, selling an estimated $9.93K and leaving 51,752 shares worth $18.7M. The position accounts for 3.84% of the portfolio, ranked #11.
O'Keefe Stevens Advisory first reported a position in AMGN in Q3 2017 and has held it in 35 quarters since. 1,244 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- O'Keefe Stevens Advisory held 51,752 shares of Amgen worth $18.7M as of Q2 2026.
- O'Keefe Stevens Advisory sold 29 Amgen shares in Q2 2026, an estimated $9.93K.
- Amgen made up 3.84% of O'Keefe Stevens Advisory's portfolio in Q2 2026, its #11 holding.
- O'Keefe Stevens Advisory first reported a position in Amgen in Q3 2017 and has held it in 35 quarters since.
- 1,244 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on O'Keefe Stevens Advisory's 13F filing for Q2 2026, filed 13 Jul 2026.